Category | Characteristic | San Diego metrics | Tijuana metrics |
---|---|---|---|
Online Communication and Partnership Profile | Facebook presence | 76.9% | 65.5% |
Twitter presence | 43.5% | 26.4% | |
Other online presence | 63.9% | 37.3% | |
Address provided | 97.3% | 88.2% | |
Phone number provided | 99.3% | 97.3% | |
Email provided | 63.9% | 68.2% | |
Contact form | 95.9% | 85.5% | |
Multiple clinics in area | 27.9% | 6.4% | |
Partners mentioned | 2.0% | 12.7% | |
Links to suppliers or other clinics | 3.4% | 10.9% | |
Language: English | 95.2% | 40.0% | |
Language: Spanish | 0.0% | 40.0% | |
Language: Both English and Spanish | 4.8% | 20.0% | |
Partner location: Mexico | 0.0% | 78.6% | |
Partner location: USA | 100% | 0.0% | |
Partner location: Mexico and USA | 0.0% | 1.0% | |
Partner location: Other | 0.0% | 2.0% | |
Claims to Scientific Legitimacy | Affiliation with academia | 7.5% | 0.9% |
Affiliation with hospital/medical center | 12.9% | 13.6% | |
Affiliation with society/network | 27.9% | 13.6% | |
Affiliation with other authority | 2.0% | 6.4% | |
Clinical trials conducted | 5.4% | 5.5% | |
License for regenerative medicine | 0.0% | 11.8% | |
Accreditation from professional org. | 25.9% | 20.9% | |
FDA Approval | 7.5% | 1.8% | |
COFEPRIS Approval | 0.0% | 12.7% | |
Patent pending | 0.0% | 0.0% | |
Patent approved | 0.7% | 0.9% | |
Evidence cited: any (including testimonials) | 39.5% | 33.6% | |
Evidence cited: peer-reviewed | 9.5% | 5.5% | |
Evidence cited: lay press/blogs | 4.8% | 3.6% | |
Evidence cited: self-publication | 17.7% | 6.4% | |
Intervention Details | Number of diseases treated (mean) | 6.04 | 8.15 |
Cost per Session | $1523.04 | $3691 | |
PRP Offered | 87.1% | 67.3% | |
Follow-up Mentioned | 6.1% | 11.8% | |
Expectation: Unclear | 17% | 49.1% | |
Expectation: Improvement | 76.9% | 48.2% | |
Expectation: Cure | 0.7% | 0.0% | |
Risk: Not mentioned | 41.5% | 55.5% | |
Risk: Safe | 51.0% | 38.2% | |
Risk: Minor | 5.4% | 6.0% | |
Risk: Moderate | 2.0% | 0.0% | |
Risk: Major | 0.0% | 0.0% | |
Tissue origin: USA | 84.4% | 0.9% | |
Tissue origin: Mexico | 0.0% | 60.0% | |
Tissue origin: Unspecified | 15.6% | 39.1% | |
Tissue source: Autologous | 84.4% | 61.8% | |
Tissue source: Allogenic | 13.6% | 20.0% | |
Tissue source: Xenogenic | 1.4% | 1.8% | |
Tissue source: Unspecified | 10.9% | 32.7% | |
Cell type: Adult Stem Cells | 21.8/% | 29.1% | |
Cell type: Embryonic Stem Cells | 0.0% | 3.6% | |
Cell type: IPSC | 0.0% | 0.0% | |
Cell type: Cord, amniotic, or placental | 13.6% | 8.2% | |
Cell type: Unspecified | 11.6% | 26.4% | |
Route: Intrathecal | 0.7% | 8.2% | |
Route: Oral | 0.0% | 0.0% | |
Route: Topical | 0.7% | 0.9% | |
Route: Intravenous | 6.8% | 14.5% | |
Route: Intramuscular | 0.7% | 4.5% | |
Route: Other | 82.3% | 50.9% | |
Route: Unspecified | 13.6% | 42.7% |